Title: Patient Centered Care Building the Infrastructure Ross D. Martin, MD, MHA Director, Pfizer Healthcare Informatics
1Patient Centered CareBuilding the
InfrastructureRoss D. Martin, MD, MHADirector,
Pfizer Healthcare Informatics
Note These opinions shared are my own and not
necessarily those of Pfizer
- Presentation to University of MarylandSmith
School of Business CIO Forum - 3 November 2006
2Outline
- A Quick Review
- Consumer Empowerment
- The role of the Pharmaceutical Industry
- Next Steps
3The US Connectivity Roadmap
Evidence-Based Medicine
National Databases
National Health Information Infrastructure
EMR
eRx
HIPAA
Personalized Medicine
- Algorithm-driven medicine and decision making
- Population-based outcomes and cost information
readily available to consumers, physicians, payers
- Streamlined information retrieval valuable for
epidemiology
- Integrated database allow decision support tools
- Gains in accuracy and connectivity enhance safety
and efficiency
- Electronic transactions for the business of
healthcare
4Definition of Standards
GENERIC DEFINITION An agreed upon set of
parameters that facilitates a marketplace or
other exchange
SDO Standards Development Organization Usually
accredited by the American National Stnadards
Institute (ANSI) or the International Standards
Organization (ISO)
5Lack of Standards Creates Inefficiencies
but Protects Proprietary Interests
San Francisco
Miami
6Standards Alone Create Efficiencies
but Multiple Networks are Still Required
San Francisco
Miami
7The Promise of Technology Standards
Proprietary Transactions (EDI)
Internet Standards-based XML
8An Interoperable, Interconnected Network
Hospital
Payer
Patient
Pharma
Physician
Hospital
9Interoperability and Standards
- Vocabulary mapping
- International (realm)-specific context
GlobalData Exchanges
- Population health monitoring
National Databases Exchanges
- Vocabulary
- Messaging
- Patient/provider identifiers
- Electronic signatures
Community Data Repositories/Exchanges
Few Standards Required
- Application-to-application customized data mapping
Complexity ?
Unified Office System
Focus on Local Functionality
- User interface
- Clinical tools
Individual Systems/Applications
Storing/Accessing Information
10Broad Charge What are we trying to accomplish?
- Make recommendations to the Community to gain
widespread adoption of a personal health record
(PHR) that is easy to use, portable,
longitudinal, affordable, and consumer centered. - The critical components that support widespread
adoption are - Functionality
- Interoperability
- Consumer awareness
- Business models
11Current StateWhere are we today?
- Lack of consumer awareness and engagement
- Standalone PHRs available, but uptake poor
- Manual entry of data
- Lack of interface with clinical data sources
- Lack of communication tools
- Good experience with integrated PHR/EHR
- Primarily available in integrated delivery
systems - Relatively rich functionality, but tethered to
single provider organization - Lack of portability
- Lack of a sustainable business model for PHR
sponsors - -------------------------------------------
- Overall small fraction of population using PHR
12End-State VisionWhere do we want to end up?
Comprehensive Consumer Experience
13End-State VisionWhere do we want to end up?
- Widespread adoption of PHRs supporting health and
wellness - Comprehensive, longitudinal, record about an
individuals health acquired from all relevant
sources data - Timely, understandable, context-sensitive health
information from trusted sources knowledge - Tools that support an empowered consumer taking
an active role in managing his/her health - Tools to facilitate communication with health
care team and caregivers - Uniform privacy protections for personal health
information that follow the data and give
patients control of their PHI
14End-State Vision Components Needed
- Interoperability technical standards
- Terminology
- Health information exchange and data portability
(among PHRs and EHRs) - Security (including authentication,
authorization, data access control) - Interoperable policies
- Uniform privacy protection that transcends local
and state boundaries - Authorizations
- Licensure
- Widespread adoption of interoperable EHRs
- Nationwide Health Information Network that
facilitates sharing of personal health
information to authorized users under the control
of consumers
15Mid-State VisionAchievable Goals in 4-6 Years
- Majority of consumers aware of the role and value
of PHRs as tools to support their health - Industry standards exist for core functionality
of PHRs - CCHIT certification for EHRs include requirement
of PHR interoperability - Multiple data streams (e.g., lab, pharmacy, EHRs,
claims) from health data sources populate PHRs
following interoperability standards - Robust privacy protections exist for personal
health information in PHRs - Business models and incentives emerging to
support sustainable operation of PHRs for
consumers
16Key Enablers for Accelerating Adoption of PHRs
- Public education about PHRs from trusted sources
- Comprehensive privacy protection for portable
personal health information - Certification for core PHR functions,
interoperability, security and access control - Greater adoption of EHRs and electronic
prescribing systems among providers - Automated population of PHRs with clinical data
from multiple sources employing interoperability
standards - Development of standards for consumer-focused,
evidence-based educational information and
decision support tools
17Priorities to Drive PHR Adoption
- Near Term
- Lab results
- List of conditions and allergies
- Prescription refills and renewals
- Administrative features
- Reminders for patients
- Subsequent
- Online consultation
- Summaries of health care encounters
- Endorsed educational information
- Decision support
- Patient health outcomes
18Lessons from Today
- The Seven Virtues (Web 2.0)
- Be Generous
- Share
- Be Polite
- Be Open
- Listen
- Respect Individuals
- Diligence Wins
19Current State The Scale of Clinical Research
- 2004/5 biomedical research expenditures
- NIH 28.5B
- Pharma 30.6B
- Biotech 19.8B
- Devices 10.8B
- Other 6.5B
- Total 96.2B
- Costs from Moses et al JAMA 2941333-1342
20PHRs and Clinical Research
- Ross Go to the Whiteboard!
21Thank You!
ross.martin_at_pfizer.com www.rossmartinmd.com